Benzinga | Mar 4, 2021 07:20AM EST

EyePoint Pharmaceuticals Q2 EPS $(1.07) Down From $(0.98) YoY, Sales $7.13M Down From $8.63M YoY

EyePoint Pharmaceuticals (NASDAQ:EYPT) reported quarterly losses of $(1.07) per share. This is a 9.18 percent decrease over losses of $(0.98) per share from the same period last year. The company reported $7.13 million in sales this quarter. This is a 17.40 percent decrease over sales of $8.63 million the same period last year.